MedTrace Logo

Oral Supplementation With a Formulation Based on Cetylated Fatty Acids for Post-fracture Long Bone Healing

NCT07299851 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-12-23

No results posted yet for this study

Summary

This clinical study aims to evaluate the potential benefits of a formulation based on Cetylated Fatty Acids in improving fracture healing of long bones in the lower limbs. The investigational product is administered orally over a 12-week period. Study procedures are limited to standard imaging techniques (radiography and echography), blood sampling, and completion of validated quality of life questionnaires.

Conditions

  • Fracture Femur
  • Fracture Tibia

Interventions

DIETARY_SUPPLEMENT

CFA-based food supplement

oral gel containing cetilated fatty acids

OTHER

Placebo

oral gel coloured and flavoured as the IP

Sponsors & Collaborators

  • Artialis

    collaborator INDUSTRY

  • Pharmanutra S.p.a.

    lead INDUSTRY

Principal Investigators

  • Jan Van Meirhaeghe · Department of Orthopaedics and Traumatology Ghent University Hospital (UZ Gent), Belgium

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-01
Primary Completion
2026-05-31
Completion
2026-06-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07299851 on ClinicalTrials.gov